Search

Author/Creator Hodkinson, Brendan

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib. (3rd May 2021)

Authors:
Balasubramanian, Sriram; Wang, Songbai; Major, Christopher; Hodkinson, Brendan; Schaffer, Michael; Sehn, Laurie H.; Johnson, Peter; Zinzani, Pier Luigi; Carey, Jodi; Shreeve, S. Martin; Sun, Steven; Gerecitano, John; Vermeulen, Jessica; Staudt, Louis M.; Wilson, Wyndham
Journal:
British journal of haematology
Issue:
Volume 194:Number 1(2021)
Page Start:
83
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial. Issue 4 (30th August 2022)

Authors:
Zhu, Jun; Hong, Xiaonan; Song, Yu Qin; Hodkinson, Brendan; Balasubramanian, Sriram; Wang, Songbai; Zhang, Qingyuan; Shi, Yuankai; Huang, Huiqiang; Zhang, Huilai; Zhu, Yan; Shreeve, Stephen Martin; Sun, Steven; Wang, Ze; Wang, Xiaocan; Fan, Yue; Wilson, Wyndham; Vermeulen, Jessica
Journal:
EJHaem
Issue:
Volume 3:Issue 4(2022)
Page Start:
1154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. (17th November 2021)

Authors:
Balasubramanian, Sriram; Hodkinson, Brendan; Schuster, Stephen J.; Fowler, Nathan H.; Trotman, Judith; Hess, Georg; Cheson, Bruce D.; Schaffer, Michael; Sun, Steven; Deshpande, Sanjay; Vermeulen, Jessica; Salles, Gilles; Gopal, Ajay K.
Journal:
Cancer medicine
Issue:
Volume 11:Number 1(2022)
Page Start:
61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗